Automated description from the Alliance of Genome Resources (Release 9.0.0)
Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific; RNA polymerase II cis-regulatory region sequence-specific DNA binding activity; and protein homodimerization activity. Acts upstream of or within positive regulation of canonical NF-kappaB signal transduction. Predicted to be located in cytosol and plasma membrane. Predicted to be active in nucleus. Is expressed in several structures, including brain; genitourinary system; gut; hemolymphoid system gland; and liver and biliary system. Orthologous to human LRRFIP1 (LRR binding FLII interacting protein 1).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.